HealthEquity, Inc. (NASDAQ:HQY) Director Sells $446,487.50 in Stock

HealthEquity, Inc. (NASDAQ:HQYGet Free Report) Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now owns 84,969 shares of the company’s stock, valued at approximately $6,597,842.85. The trade was a 6.34 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

HealthEquity Price Performance

HQY stock traded up $1.17 during midday trading on Friday, reaching $81.11. 342,430 shares of the company’s stock traded hands, compared to its average volume of 756,988. The company has a 50-day simple moving average of $98.22 and a two-hundred day simple moving average of $96.27. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The company has a market cap of $7.02 billion, a price-to-earnings ratio of 74.54, a PEG ratio of 1.60 and a beta of 0.49.

Analyst Ratings Changes

A number of brokerages recently issued reports on HQY. The Goldman Sachs Group dropped their target price on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research report on Thursday, March 27th. Barrington Research reissued an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday. Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Finally, KeyCorp dropped their price objective on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Monday, March 24th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $112.58.

View Our Latest Research Report on HealthEquity

Institutional Investors Weigh In On HealthEquity

A number of institutional investors have recently made changes to their positions in HQY. Ameritas Investment Partners Inc. grew its position in shares of HealthEquity by 0.3% during the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company’s stock worth $3,248,000 after buying an additional 88 shares during the period. Smartleaf Asset Management LLC increased its position in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after buying an additional 98 shares in the last quarter. Louisiana State Employees Retirement System grew its stake in HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after acquiring an additional 100 shares during the period. Oregon Public Employees Retirement Fund increased its stake in HealthEquity by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock worth $1,706,000 after purchasing an additional 100 shares in the last quarter. Finally, State of Michigan Retirement System raised its holdings in shares of HealthEquity by 0.5% during the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock worth $1,988,000 after acquiring an additional 100 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Company Profile

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

See Also

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.